HOME >> BIOLOGY >> NEWS
Epigenetic studies will provide a better understanding of disease

From 26-28 March, the Institute for Research in Biomedicine (IRB Barcelona) will bring together 20 internationally recognised scientists from the USA and Europe working in epigenetics to present their latest work. Invited by Ferran Azorn, principal investigator at IRB Barcelona, and Tony Kouzarides, director of the Gurdon Institute in the United Kingdom, these scientists will participate in a new Barcelona BioMed Conference, one of a series organised jointly by IRB Barcelona and the BBVA Foundation. The conference will be held in the Auditorium (Tower D) of the Barcelona Science Park.

Epigenetics emerged on the scene in the 1990s. Researchers discovered that chromatin, the complex formed by DNA and histones, -proteins that bind strongly to DNA, thereby packaging it in chromosomes-, regulate gene expression. This additional layer of regulatory instructions, which are not held in DNA, comprise the epigenetic code.

Epigenetic differences explain, for example, why two cloned organisms are not the same or why twins develop illnesses of distinct genetic origin. Epigenetic studies promise not only to have a direct impact on health and our understanding of the relations between the environment and genetics but also to provide an explanation of basic aspects of cell biology. The co-organiser of the conference, Ferran Azorn, head of the "Chromatin Structure and Function" group at IRB Barcelona, comments that "deciphering and understanding the epigenome will shed light on fundamental processes in cell physiology. This knowledge will improve our understanding of the development of tumours and other diseases, and may lead to the design of new treatments for these conditions". A new family of epigenetic drugs, designed to reverse the changes in the epigenome that occur during the development of several kinds of cancer, is currently available. Several of these pharmacological agents are now being used to treat some types of leukaemia and breast cancer.


'"/>

Contact: Snia Armengou
sarmengou@pcb.ub.es
34-934-037-255
Institute for Research in Biomedicine (IRB)
19-Mar-2007


Page: 1 2

Related biology news :

1. Epigenetics to shape stem cell future
2. Epigenetic drugs, promising for breast cancer treatment
3. New view of cancer: Epigenetic changes come before mutations
4. Epigenetic activity silences Rb2/P130 gene in lung cancer
5. New studies on goats milk show it is more beneficial to health than cows milk
6. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
7. Obtaining valid consent for doing large genetic studies in developing countries
8. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
9. New studies link the environment to Parkinsons disease
10. Ewwwww! UCLA anthropologist studies evolutions disgusting side
11. Genetic studies endow mice with new color vision

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... ... January 27, 2020 , ... ... is a noted investor, tech entrepreneur, and former senior management consultant at McKinsey ... Broadline Capital, the global alternative investment firm. , “Chris Thorne has exceptional ...
(Date:1/24/2020)... ... 2020 , ... The Rockies Venture Club and Colorado BioScience ... bioscience companies in the state. , “Colorado has a world-class life ... need to innovate and grow. This program will mobilize capital within the ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... mature red blood cells from stem cells. The red blood cells are ... under strictly controlled conditions, for transfusion therapy and replaces the need for a ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... DALLAS (PRWEB) , ... January 22, 2020 , ... ... presented new developments in the cosmetic surgery industry at two recent North American ... Canadian investors at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and ... editing. The partners have agreed to co-develop and market a portfolio of CRISPR ... pre-clinical programs. Over the longer-term, the parties aim to develop a COBO branded ...
(Date:1/10/2020)... ... January 09, 2020 , ... Phlexglobal, the leading provider ... of Cunesoft, a move that expands the company’s portfolio of best-of-breed technologies designed ... , Based in Munich, Germany, Cunesoft provides intelligent software and expert services for ...
(Date:1/8/2020)... Conn. (PRWEB) , ... January 08, 2020 , ... ... whose exceptional quality and care helps couples and individuals grow their family, has ... prestigious Top Doc award by Castle Connolly. Since 1991, the renowned publishing company ...
Breaking Biology Technology:
Cached News: